David Gerber

This inventor holds 1 USPTO granted patent. Top assignees: Quiver Bioscience, Inc., Quiver Holdings Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Gerber. Retrieved from https://idiyas.com/inventor/david-gerber-5mac8o12

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Gerber: Innovator in Therapeutics

Introduction

David Gerber is a notable inventor recognized for his contributions to the field of therapeutics. He has developed innovative solutions aimed at addressing specific medical conditions, showcasing his commitment to advancing healthcare.

Latest Patents

David Gerber holds a patent titled "Therapeutics for Syngap Haploinsufficiency." This patent represents his dedication to finding effective treatments for complex health issues, highlighting his role as a pioneer in therapeutic innovations. He has 1 patent to his name.

Career Highlights

Throughout his career, David has worked with several companies, including Quiver Holdings Inc. and Quiver Bioscience, Inc. His experience in these organizations has allowed him to contribute significantly to the development of new therapeutic approaches.

Collaborations

David has collaborated with notable professionals in his field, including Graham T. Dempsey and Matt McCabe. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

David Gerber's contributions to therapeutics exemplify the spirit of innovation in the medical field. His work continues to inspire advancements that can improve patient outcomes and enhance the quality of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…